Form 8.3 -AbbVie Inc
11 Maggio 2020 - 4:07PM
UK Regulatory
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 08(th) May 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 67,865,949 4.59565%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 67,865,949 4.59565%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 300 84.03
-------------- ----------------------------- -----------------------
Purchase 1,700 84.04
-------------- ----------------------------- -----------------------
Purchase 14,900 83.96
-------------- ----------------------------- -----------------------
Purchase 1,400 82.79
-------------- ----------------------------- -----------------------
Purchase 8,100 83.96
-------------- ----------------------------- -----------------------
Purchase 500 83.96
-------------- ----------------------------- -----------------------
Purchase 1,400 83.96
-------------- ----------------------------- -----------------------
Purchase 1,400 83.96
-------------- ----------------------------- -----------------------
Purchase 400 83.96
-------------- ----------------------------- -----------------------
Purchase 146 83.96
-------------- ----------------------------- -----------------------
Purchase 200 83.96
-------------- ----------------------------- -----------------------
Purchase 128,760 83.96
-------------- ----------------------------- -----------------------
Purchase 1,044 83.96
-------------- ----------------------------- -----------------------
Purchase 210 83.96
-------------- ----------------------------- -----------------------
Purchase 225 83.96
-------------- ----------------------------- -----------------------
Purchase 300 83.61
-------------- ----------------------------- -----------------------
Sale 1,400 83.96
-------------- ----------------------------- -----------------------
Sale 300 83.96
-------------- ----------------------------- -----------------------
Sale 30,800 83.96
-------------- ----------------------------- -----------------------
Sale 200 83.96
-------------- ----------------------------- -----------------------
Sale 400 83.96
-------------- ----------------------------- -----------------------
Sale 1,600 83.96
-------------- ----------------------------- -----------------------
Sale 49,775 83.96
-------------- ----------------------------- -----------------------
Sale 10,971 83.96
-------------- ----------------------------- -----------------------
Sale 850 83.96
-------------- ----------------------------- -----------------------
Sale 2,300 83.96
-------------- ----------------------------- -----------------------
Sale 2,800 83.96
-------------- ----------------------------- -----------------------
Sale 1,700 83.96
-------------- ----------------------------- -----------------------
Sale 2,200 83.61
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- ---------------
Date of disclosure 11(th) May 2020
------------------------------------------------------- ---------------
Contact name Lionel Colaco
------------------------------------------------------- ---------------
Telephone number 020 33956098
------------------------------------------------------- ---------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- ---------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- ---------------
(END) Dow Jones Newswires
May 11, 2020 10:07 ET (14:07 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Allergan (LSE:0Y7T)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Allergan (LSE:0Y7T)
Storico
Da Gen 2024 a Gen 2025
